Augustijns Patrick, Wuyts Benjamin, Hens Bart, Annaert Pieter, Butler James, Brouwers Joachim
Drug Delivery and Disposition, KU Leuven, Leuven, Belgium.
Drug Delivery and Disposition, KU Leuven, Leuven, Belgium.
Eur J Pharm Sci. 2014 Jun 16;57:322-32. doi: 10.1016/j.ejps.2013.08.027. Epub 2013 Aug 29.
The purpose of this paper is to collate all recently published solubility data of orally administered drugs in human intestinal fluids (HIF) that were aspirated from the upper small intestine (duodenum and jejunum). The data set comprises in total 102 solubility values in fasted state HIF and 37 solubility values in fed state HIF, covering 59 different drugs. Despite differences in the protocol for HIF sampling and subsequent handling, this summary of HIF solubilities provides a critical reference data set to judge the value of simulated media for intestinal solubility estimation. In this regard, the review includes correlations between the reported solubilizing capacity of HIF and fasted or fed state simulated intestinal fluid (FaSSIF/FeSSIF). Correlating with HIF solubilities enables the optimal use of solubility measurements in simulated biorelevant media to obtain accurate estimates of intestinal solubility during drug development. Considering the fraction of poorly soluble new molecular entities in contemporary drug discovery, adequate prediction of intestinal solubility is critical for efficient lead optimization, early candidate profiling, and further development.
本文的目的是整理所有最近发表的口服药物在从小肠上部(十二指肠和空肠)吸出的人体肠液(HIF)中的溶解度数据。该数据集总共包括102个禁食状态下HIF中的溶解度值和37个进食状态下HIF中的溶解度值,涵盖59种不同药物。尽管HIF采样及后续处理的方案存在差异,但这份HIF溶解度总结提供了一个关键的参考数据集,用于判断模拟介质对肠道溶解度估算的价值。在这方面,该综述包括了所报道的HIF溶解能力与禁食或进食状态模拟肠液(FaSSIF/FeSSIF)之间的相关性。与HIF溶解度相关联能够在药物研发过程中最优地利用模拟生物相关介质中的溶解度测量结果,以获得肠道溶解度的准确估算值。考虑到当代药物研发中难溶性新分子实体的占比,对肠道溶解度进行充分预测对于高效的先导化合物优化、早期候选药物分析及进一步开发至关重要。